Congratulations to our researchers David Hipfner, Javier Di Noia, Jean-François Côté and Mohan Malleshaiah who were selected in the last grants competition of the Cancer Research Society. They will each be granted a financial support of $ 120,000 over two years, to develop cutting-edge and promising research projects in oncology.
- David Hipfner, Director of the Epithelial Cell Biology Research Unit, will work on a model of intercellular growth signalling using a type of fly called Drosophila.
- Javier Di Noia, Director of the Molecular Biology of the B cell Research Unit, will explore an orphan deaminase as an element of resistance to chemotherapy. A study that is partially funded by the Leukemia & Lymphoma Society of Canada.
- Jean-François Côté, Director of the Cytoskeleton Organization and Cell Migration Research Unit, will seek to shed light on the way the molecule called Peak1 promotes the progression of a very aggressive breast cancer, called triple negative breast cancer, by defining the functions of the protein involved in tumour growth and metastasis. The project is partially supported by the Quebec Breast Cancer Foundation.
- Mohan Malleshaiah, Director of the Stem Cells and Cell Reprogramming Research Unit, will focus on the analysis of single cells involved in the epithelial-to-mesenchymal transition in pancreatic cancer, a disease with a very low survival rate. The project will be partially funded by the Cancer Institute of the Canadian Institutes of Health Research.
We wish them a good continuation in their work!
